Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hubbard

Showing results (511-520 of 562) with videos related to

Pageof 57
Sort By:
Nature Communications|October 18, 2024
Molecular mechanisms of re-emerging chloramphenicol susceptibility in extended-spectrum beta-lactamase-producing EnterobacteralesFabrice E Graf, Richard N Goodman, Sarah Gallichan, et al.
BMC Cancer|July 29, 2017
Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreasMatthew H G Katz, Fang-Shu Ou, Joseph M Herman, et al.
Cancer Immunology Research|April 3, 2016
De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research InstituteIra Mellman, Vanessa M Hubbard-Lucey, Matthew J Tontonoz, et al.
Journal of the National Cancer Institute|June 14, 2014
Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147Wilson I Gonsalves, Michelle R Mahoney, Daniel J Sargent, et al.
Journal of Environmental Management|July 12, 2014
Metrics to assess ecological condition, change, and impacts in sandy beach ecosystemsThomas A Schlacher, David S Schoeman, Alan R Jones, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantationGabrielle L Goldberg, Onder Alpdogan, Stephanie J Muriglan, et al.
Blood|July 23, 2005
CCR2 is required for CD8-induced graft-versus-host diseaseTheis H Terwey, Theo D Kim, Adam A Kochman, et al.
Investigational New Drugs|August 31, 2021
A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinomaDaniel H Ahn, Pedro Luiz Serrano Uson Junior, Peter Masci, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 2, 2020
Association of tumor genomic factors and efficacy for metastasis-directed stereotactic body radiotherapy for oligometastatic colorectal cancerKrishan R Jethwa, Samuel Jang, Trey C Mullikin, et al.
Catalysts (Basel, Switzerland)|November 21, 2022
Zinc-Acetate-Amine Complexes as Precursors to ZnO and the Effect of the Amine on Nanoparticle Morphology, Size, and Photocatalytic ActivityJerry D Harris, Emily A Wade, Emmaline G Ellison, et al.
Pageof 57

Showing results (511-520 of 562) with videos related to

Sort By:
Pageof 57
Nature Communications|October 18, 2024
Molecular mechanisms of re-emerging chloramphenicol susceptibility in extended-spectrum beta-lactamase-producing EnterobacteralesFabrice E Graf, Richard N Goodman, Sarah Gallichan, et al.
BMC Cancer|July 29, 2017
Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreasMatthew H G Katz, Fang-Shu Ou, Joseph M Herman, et al.
Cancer Immunology Research|April 3, 2016
De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research InstituteIra Mellman, Vanessa M Hubbard-Lucey, Matthew J Tontonoz, et al.
Journal of the National Cancer Institute|June 14, 2014
Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147Wilson I Gonsalves, Michelle R Mahoney, Daniel J Sargent, et al.
Journal of Environmental Management|July 12, 2014
Metrics to assess ecological condition, change, and impacts in sandy beach ecosystemsThomas A Schlacher, David S Schoeman, Alan R Jones, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantationGabrielle L Goldberg, Onder Alpdogan, Stephanie J Muriglan, et al.
Blood|July 23, 2005
CCR2 is required for CD8-induced graft-versus-host diseaseTheis H Terwey, Theo D Kim, Adam A Kochman, et al.
Investigational New Drugs|August 31, 2021
A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinomaDaniel H Ahn, Pedro Luiz Serrano Uson Junior, Peter Masci, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 2, 2020
Association of tumor genomic factors and efficacy for metastasis-directed stereotactic body radiotherapy for oligometastatic colorectal cancerKrishan R Jethwa, Samuel Jang, Trey C Mullikin, et al.
Catalysts (Basel, Switzerland)|November 21, 2022
Zinc-Acetate-Amine Complexes as Precursors to ZnO and the Effect of the Amine on Nanoparticle Morphology, Size, and Photocatalytic ActivityJerry D Harris, Emily A Wade, Emmaline G Ellison, et al.
Pageof 57